£1.0M
The financing round was led by The FSE Group with backing from new and existing angel investors.
FD
Fuse Diagnostics
Fuse Diagnostics develops rapid molecular testing platforms for decentralised point-of-need applications.
Cambridge, UK—Founded 2022
£1.0MTotal raised
Fuse Diagnostics develops next-generation molecular testing platforms designed to provide laboratory-quality diagnostic capabilities for decentralised industrial and life science applications.
Filed accounts
Net current assets
Members only
Total assets less current liabilities
Members only
Net assets
Members only
Shareholders' funds
Members only
Fixed assets
Members only
Current assets
Members only
Cash, assets and headcount from Fuse Diagnostics's latest Companies House filing — with year-on-year movement, free with a Winfred account.